Delivery Order 75F40121D00033-75F40124F19003
Award Date 1/30/24
Potential Completion Date 9/1/24
Potential Value $205K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denver, CO 80204, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) awarded a delivery order valued at $816,801.67 to Denver Health and Hospital Authority (doing business as Denver Health) on September 20, 2019, for work related to improving the quality and representativeness of Treatment Center Program data used in post-marketing surveillance of prescription and over-the-counter drug abuse. The contract, which operates under firm fixed-price terms with an ultimate completion date of March 5, 2026, represents work to be...
- This is a federal contract awarded by the Department of Health and Human Services' Food and Drug Administration to the Denver Health and Hospital Authority. The $427,972.40 contract is for a "DATA ENHANCEMENT PROJECT" to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance data. The work is being performed under the FDA Prescription Drug Abuse Summary Reports contract vehicle. The contract does not have a set-aside designation. As a U.S. local...
- The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price definitive contract valued at $307,622.10 to the Denver Health and Hospital Authority, doing business as Denver Health, to evaluate the impact of flow restrictors on pediatric exposures to liquid single-ingredient acetaminophen. This contract was awarded under a Broad Agency Announcement (BAA) solicitation and does not have a set-aside designation. Denver Health is a large healthcare provider and academic medical center...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded a $249,998 firm fixed price purchase order to Denver Health And Hospitals Authority, doing business as Denver Health, for the Psychedelic Online Motivations & Contextual Use Survey. Under this contract, Denver Health will deliver a survey to collect information relating to motivations and contextual use of psychedelic substances. The contract was awarded through open market...
- This is a $50,376.00 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Colorado Department of Public Health & Environment (CDPHE). The contract is for "2025 NDI DATA" and has an ultimate completion date of May 1, 2026. CDPHE is a U.S. state government entity that has extensive experience executing federal contracts and grants across a range of public health and environmental programs. While this specific contract does...
- This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (HHS/FDA) to Inflexxion, Inc., a for-profit organization. The contract, with a potential value of $754,500.62, is for a DATA ENHANCEMENT PROJECT under the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The project aims to provide DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA. The contract does...
- Denver Solutions, LLC, an FDA-registered 503B outsourcing facility specializing in compounded sterile pharmaceuticals, was awarded a delivery order valued at $53,375 by Veterans Integrated Service Network 23 (VISN 23) on October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed in Greenwood Village, Colorado, and involves the provision of 503B compounded pharmaceutical products to support VA...
- This contract award for $1,786,050.54 was issued on September 30, 2024 by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to the Maryland Department of Health (MDH). The purpose is to provide funding for 4,760 units of blood (UB) and 1,190 other units through MDH's Prevention and Health Promotion Administration (PHPA) division. This is a delivery order contract without a set-aside designation, with a period of performance through May 29, 2026. MDH is the prime...
- This federal contract was awarded by the Food and Drug Administration (FDA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for a study titled "Pediatric Pulmonary Hypertension Actigraphy Endpoint Clinical Study and Data Submission" with a ceiling value of $218,721.00. It is a definitive, firm fixed-price contract with a completion date of March 30, 2019. The contract does not have a set-aside designation. The...
- The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...